EBS Competitors & Alternatives

Compare Emergent Biosolutions Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

EBS

Main Stock
$5.79
-1.70%
Tradestie Score
47
Market Cap
$490.30M
Revenue Growth
-52.4%
Analyst Upside
+72.7%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Vaccine Manufacturing
Competitive Moat: None
Core Technology Stack: Vaccine development, Biologics manufacturing, Countermeasure production
Major Customers 3
US Government (BARDA, DoD, CDC) State/local health agencies Commercial pharmaceutical partners
Critical Suppliers 3
Biologics raw material providers Contract research organizations Specialized fill-finish facilities
Direct Ecosystem Rivals 3

Top Competitors

49 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
PCRX Pacira BioSciences, Inc. Common Stock
$36.46
$1.14B 39.2 49 Compare
COLL Collegium Pharmaceutical, Inc. Common Stock
$25.32
+1.48%
$1.11B 22.9 36 Compare
CRON Cronos Group Inc. Common Share
$3.38
-0.88%
$1.02B 21.3 48 Compare
VIR Vir Biotechnology, Inc. Common Stock
$9.96
-17.82%
$791.82M - 42 Compare
SIGA SIGA Technologies Inc.
$2.74
-5.19%
$660.92M 280.5 45 Compare
ESPR Esperion Therapeutics, Inc.
$3.18
-0.31%
$584.71M - 53 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$63.93
+4.04%
$543.32M 39.9 33 Compare
TKNO Alpha Teknova, Inc. Common Stock
$8.21
-1.02%
$340.89M - 38 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.83
-0.41%
$237.15M 5.4 35 Compare
BVNRY BVNRY
- - - - Compare

Data updated: Nov 16, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

49 stocks in this industry